159 related articles for article (PubMed ID: 26215394)
61. Pathogenesis of Semliki Forest virus encephalitis.
Fazakerley JK
J Neurovirol; 2002 Dec; 8 Suppl 2():66-74. PubMed ID: 12491154
[TBL] [Abstract][Full Text] [Related]
62. Expression of heterologous proteins in cultured rat hippocampal neurons using the Semliki Forest virus vector.
Olkkonen VM; Liljeström P; Garoff H; Simons K; Dotti CG
J Neurosci Res; 1993 Jul; 35(4):445-51. PubMed ID: 8360951
[TBL] [Abstract][Full Text] [Related]
63. Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor.
Näslund TI; Uyttenhove C; Nordström EK; Colau D; Warnier G; Jondal M; Van den Eynde BJ; Liljeström P
J Immunol; 2007 Jun; 178(11):6761-9. PubMed ID: 17513723
[TBL] [Abstract][Full Text] [Related]
64. Insertion of EGFP into the replicase gene of Semliki Forest virus results in a novel, genetically stable marker virus.
Tamberg N; Lulla V; Fragkoudis R; Lulla A; Fazakerley JK; Merits A
J Gen Virol; 2007 Apr; 88(Pt 4):1225-1230. PubMed ID: 17374766
[TBL] [Abstract][Full Text] [Related]
65. High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system.
Lundström K; Mills A; Buell G; Allet E; Adami N; Liljeström P
Eur J Biochem; 1994 Sep; 224(3):917-21. PubMed ID: 7523121
[TBL] [Abstract][Full Text] [Related]
66. The avirulent A7 Strain of Semliki Forest virus has reduced cytopathogenicity for neuroblastoma cells compared to the virulent L10 strain.
Atkins GJ
J Gen Virol; 1983 Jun; 64 (Pt 6)():1401-4. PubMed ID: 6854273
[TBL] [Abstract][Full Text] [Related]
67. Safety of an Oncolytic Myxoma Virus in Dogs with Soft Tissue Sarcoma.
MacNeill AL; Weishaar KM; Séguin B; Powers BE
Viruses; 2018 Jul; 10(8):. PubMed ID: 30060548
[TBL] [Abstract][Full Text] [Related]
68. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.
Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z
Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451
[TBL] [Abstract][Full Text] [Related]
69. Biodistribution and tumor infectivity of semliki forest virus vectors in mice: effects of re-administration.
Rodriguez-Madoz JR; Prieto J; Smerdou C
Mol Ther; 2007 Dec; 15(12):2164-71. PubMed ID: 17667947
[TBL] [Abstract][Full Text] [Related]
70. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.
Omar NB; Bentley RT; Crossman DK; Foote JB; Koehler JW; Markert JM; Platt SR; Rissi DR; Shores A; Sorjonen D; Yanke AB; Gillespie GY; Chambers MR
Neurosurg Focus; 2021 Feb; 50(2):E5. PubMed ID: 33524948
[TBL] [Abstract][Full Text] [Related]
71. Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon.
Vasilevska J; Skrastina D; Spunde K; Garoff H; Kozlovska T; Zajakina A
Cancer Gene Ther; 2012 Aug; 19(8):579-87. PubMed ID: 22722377
[TBL] [Abstract][Full Text] [Related]
72. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
Ghim S; Newsome J; Bell J; Sundberg JP; Schlegel R; Jenson AB
Exp Mol Pathol; 2000 Jun; 68(3):147-51. PubMed ID: 10816383
[TBL] [Abstract][Full Text] [Related]
73. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
[TBL] [Abstract][Full Text] [Related]
74. The significance of the 3'-nontranslated region and E2 amino acid mutations in the virulence of Semliki Forest virus in mice.
Santagati MG; Määttä JA; Röyttä M; Salmi AA; Hinkkanen AE
Virology; 1998 Mar; 243(1):66-77. PubMed ID: 9527916
[TBL] [Abstract][Full Text] [Related]
75. The Capsid Protein of Semliki Forest Virus Antagonizes RNA Interference in Mammalian Cells.
Qian Q; Zhou H; Shu T; Mu J; Fang Y; Xu J; Li T; Kong J; Qiu Y; Zhou X
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694940
[TBL] [Abstract][Full Text] [Related]
76. Age-dependent and strain-related differences of virulence of Semliki Forest virus in mice.
Fleming P
J Gen Virol; 1977 Oct; 37(1):93-105. PubMed ID: 915485
[TBL] [Abstract][Full Text] [Related]
77. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
78. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.
Lucroy MD; Clauson RM; Suckow MA; El-Tayyeb F; Kalinauskas A
BMC Vet Res; 2020 Nov; 16(1):447. PubMed ID: 33208160
[TBL] [Abstract][Full Text] [Related]
80. Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine.
Nogales A; Rodriguez L; Chauché C; Huang K; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martínez-Sobrido L
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
